BioPharm International-12-15-2019

BioPharm International

Lessons from FDA 483s and cGMP Inspection Data

December 15, 2019

Features

2019 eBook

5

Production and process controls, organization and personnel were the top problems found, while packaging and labeling citations increased in 2017 and 2018.